KWR vs LIN
Valuation
Profitability
Growth
Financial Health
Dividends
AI Verdict
KWR exhibits a stark divergence between analyst optimism and fundamental health, headlined by a weak Piotroski F-Score of 2/9. While the company shows strong liquidity (Current Ratio 2.42) and impressive year-over-year earnings growth of 48.6%, current profitability is concerning with a negative profit margin (-0.13%) and negative ROE (-0.18%). The stock is currently viewed as a recovery play, supported by a 'Strong Buy' analyst consensus and a target price of $169.20, but the underlying deterministic health scores suggest significant operational instability.
LIN shows neutral fundamentals based on deterministic rules. Financial strength is stable (F-Score 4/9). Mixed signals with both opportunities and risks present.
Compare Another Pair
Related Comparisons
KWR vs LIN: Head-to-Head Comparison
This page compares Quaker Chemical Corporation (KWR) and Linde plc (LIN) across key fundamental metrics including valuation ratios, profitability margins, growth rates, financial health indicators, and dividend metrics. Each metric highlights the better-performing stock so you can quickly identify relative strengths and weaknesses.
Our AI engine independently analyzes each company's financials, competitive position, and market conditions to produce a verdict (Bullish, Neutral, or Bearish) along with key strengths and risks. Use this comparison alongside your own research to make informed investment decisions.